Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Types of spectroscopy and microscopy techniques for cancer diagnosis: a review.
Kaniyala Melanthota S, Kistenev YV, Borisova E, Ivanov D, Zakharova O, Boyko A, Vrazhnov D, Gopal D, Chakrabarti S, K SP, Mazumder N. Kaniyala Melanthota S, et al. Among authors: boyko a. Lasers Med Sci. 2022 Oct;37(8):3067-3084. doi: 10.1007/s10103-022-03610-3. Epub 2022 Jul 14. Lasers Med Sci. 2022. PMID: 35834141 Free PMC article. Review.
[Association of the Level of Serum Prolactin with Polymorphic Variants of the GRIN2A, GPM3, and GPM7 Genes in Patients with Schizophrenia Taking Conventional and Atypical Antipsychotics].
Tiguntsev VV, Gerasimova VI, Kornetova EG, Fedorenko OY, Kornetov AN, Goncharova AA, Poltavskaya EG, Boyko AS. Tiguntsev VV, et al. Among authors: boyko as. Mol Biol (Mosk). 2023 Jan-Feb;57(1):47-55. doi: 10.31857/S0026898423010159. Mol Biol (Mosk). 2023. PMID: 36976738 Russian.
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].
Boyko AN, Alifirova VM, Lukashevich IG, Goncharova ZA, Greshnova IV, Zaslavsky LG, Kotov SV, Malkova NA, Mishin GN, Parshina EV, Poverennova IY, Prakhova LN, Sivertseva SA, Smagina IV, Totolyan NA, Trinitatsky YV, Trushnikova TN, Khabirov FA, Chefranova JY, Shchur SG, Dudin VA, Pokhabov DV, Artemeva AV, Eremeeva AV, Linkova YN, Zinkina-Orikhan AV. Boyko AN, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(4):86-96. doi: 10.17116/jnevro202412404186. Zh Nevrol Psikhiatr Im S S Korsakova. 2024. PMID: 38676683 Clinical Trial. Russian.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis.
Al Assaad M, Shin N, Sigouros M, Manohar J, Antysheva Z, Kotlov N, Kiriy D, Nikitina A, Kleimenov M, Tsareva A, Makarova A, Fomchenkova V, Dubinina J, Boyko A, Almog N, Wilkes D, Escalon JG, Saxena A, Elemento O, Sternberg CN, Nanus DM, Mosquera JM. Al Assaad M, et al. Among authors: boyko a. Front Oncol. 2024 Jan 22;13:1274163. doi: 10.3389/fonc.2023.1274163. eCollection 2023. Front Oncol. 2024. PMID: 38318324 Free PMC article.
410 results